Kiromic BioPharma, Inc. (KRBP)
OTCMKTS
· Delayed Price · Currency is USD
1.615
-0.315 (-16.32%)
Feb 20, 2025, 3:00 PM EST
Kiromic BioPharma Market Cap
Kiromic BioPharma has a market cap or net worth of $2.48 million as of February 21, 2025. Its market cap has increased by 555.89% in one year.
Market Cap
2.48M
Enterprise Value
15.91M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
$1.62
Market Cap Chart
Since October 16, 2020, Kiromic BioPharma's market cap has decreased from 84.33M to 2.48M, a decrease of -97.06%. That is a compound annual growth rate of -55.58%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Feb 19, 2025 | 2.48M | 77.98% |
Dec 31, 2024 | 1.39M | 27.08% |
Dec 29, 2023 | 1.09M | -66.79% |
Dec 30, 2022 | 3.30M | -86.04% |
Dec 31, 2021 | 23.62M | -61.97% |
Dec 31, 2020 | 62.11M | -26.35% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Endo Inc. | 2.19B |
SS Innovations International | 1.72B |
Nika Pharmaceuticals | 1.02B |
Veradigm | 864.81M |
Elite Pharmaceuticals | 520.73M |
Glass House Brands | 497.07M |
CytoDyn | 367.12M |
Northwest Biotherapeutics | 326.95M |